Evidence map›Paper›PMID 22451695›Full record

ArticleThe Journal of cell biology2012

Nucleophosmin/B23 activates Aurora A at the centrosome through phosphorylation of serine 89.

David Reboutier, Marie-Bérengère Troadec, Jean-Yves Cremet, Kenji Fukasawa, Claude Prigent

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. The Aurora kinase inhibitors in cancer research and therapy.Journal of cancer research and clinical oncology · 2016
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Issues in interpreting the in vivo activity of Aurora-A.Expert opinion on therapeutic targets · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

David ReboutierCentre National de la Recherche Scientifique, Unité Mixte de Recherche UMR6290, 35043 Rennes, France.
Marie-Bérengère Troadec
Jean-Yves Cremet
Kenji Fukasawa
Claude Prigent
Centre National de la Recherche Scientifique · FRUniversité de Rennes · FRMoffitt Cancer Center · US

Funding

ROCK II-mediated regulation of centrosome duplication / centrosome amplificationR01GM087328 · NIGMS · H. LEE MOFFITT CANCER CTR & RES INST · PI FUKASAWA, KENJI · 2010 to 2013
$1.3M
NIGMS NIH HHS R01 GM087328
6 · The paper itself

Abstract

Aurora A (AurA) is a major mitotic protein kinase involved in centrosome maturation and spindle assembly. Nucleophosmin/B23 (NPM) is a pleiotropic nucleolar protein involved in a variety of cellular processes including centrosome maturation. In the present study, we report that NPM is a strong activator of AurA kinase activity. NPM and AurA coimmunoprecipitate and colocalize to centrosomes in G2 phase, where AurA becomes active. In contrast with previously characterized AurA activators, NPM does not trigger autophosphorylation of AurA on threonine 288. NPM induces phosphorylation of AurA on serine 89, and this phosphorylation is necessary for activation of AurA. These data were confirmed in vivo, as depletion of NPM by ribonucleic acid interference eliminated phosphorylation of CDC25B on S353 at the centrosome, indicating a local loss of AurA activity. Our data demonstrate that NPM is a strong activator of AurA kinase activity at the centrosome and support a novel mechanism of activation for AurA.

Indexed as

Aurora KinasesCentrosomeHeLa CellsHumansNuclear ProteinsNucleophosminPhosphorylationProtein Serine-Threonine KinasesSerineAurora KinasesNPM1 protein, humanNuclear ProteinsNucleophosminProtein Serine-Threonine KinasesSerine

Identifiers

PMID22451695
PMCPMC3317798
OpenAlexW2135158109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.